Browsing by Author "Laušević, Dragan (26647640900)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Current status of human papillomavirus vaccination implementation in central and eastern Europe(2013) ;Seme, Katja (55744916500) ;Maver, Polona J. (14056550100) ;Korać, Tina (56002965800) ;Canton, Amalia (24400908700) ;Částková, Jitka (6507194507) ;Dimitrov, Goran (57192014205) ;Filippova, Irina (55313951200) ;Hudecová, Helena (55314361800) ;Iljazović, Ermina (24075807000) ;Kaić, Bernard (6602803731) ;Kesić, Vesna (6701664626) ;Kuprevičiene, Nerija (36056929800) ;Laušević, Dragan (26647640900) ;Molnár, Zsuzsanna (26024261000) ;Perevoščikovs, Jurijs (16031935900) ;Spaczyński, Marek (7004428144) ;Stefanova, Venera (55745023200) ;Učakar, Veronika (36099649600)Poljak, Mario (55142297400)We present a review of the current implementation status of vaccination against human papillomaviruses (HPV) and available data concerning the burden of HPV infection and HPV type-specific distribution in 16 central and eastern European countries: Albania, Bosnia and Herzegovina, Bulgaria, Croatia, the Czech Republic, Estonia, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia, and The Former Yugoslav Republic of Macedonia. At least one current HPV prophylactic vaccine is registered in all central and eastern European countries except Montenegro. Six counties-Bulgaria, the Czech Republic, Latvia, Romania, Slovenia, and Former Yugoslav Republic of Macedonia-have integrated the HPV vaccination into their national immunization program and currently provide routine vaccination free of charge to the primary target population. Ten countries have not integrated HPV vaccination into the national immunization program. The key reasons for lack of implementation of HPV vaccination into the national immunization program are the high vaccine cost and negative public perception. Vaccination of males is not recommended in any country in the region. - Some of the metrics are blocked by yourconsent settings
Publication Lung cancer mortality in Montenegro, 1990 to 2015(2019) ;Nedović-Vuković, Mirjana (57188698897) ;Laušević, Dragan (26647640900) ;Ljaljević, Agima (24071083700) ;Golubović, Mileta (23034135100)Trajković, Goran (9739203200)Aim: To analyze the trend of lung cancer mortality in Montenegro from 1990 to 2015. Methods: Data on lung cancer mortality were collected from death certificates obtained from the Statistical Office of Montenegro for the period 1990-2009 and the Institute for Public Health for the period 2010-2015. Population data were obtained from the Statistical Office of Montenegro. Rates were age-standardized to the World Standard Population, and mortality trends were analyzed with the pinpoint regression. Results: In 2015, lung cancer accounted for 5.44% of all deaths and 22.92% of all cancer deaths. It was the leading cause of all cancer deaths and the third-leading cause of all deaths. A pinpoint was observed in 2004 in women and in the entire population, and in 2005 in men. The overall mortality rates increased from 1990 to 2004 by an average of 3.91% peryearand decreased from 2004 to 2015 by an average of 1.95%; which in the entire observed period resulted in an average increase of 1.3% per year. A particularly strong growth rate was observed in women, even 7.14% in the period from 1990 to 2004. Conclusion: The observed increase in lung cancer mortality warrants improved tobacco control. ©2019 Medicinska Naklada Zagreb.All rights reserved.
